Jaguar Health, Inc. Contracts & Agreements

298 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2025)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Placement Agent Common Stock Purchase Warrant between Jaguar Health, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers dated May 20, 2025
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (February 2025)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (May 13, 2025)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2025
Exchange Agreement between Streeterville Capital, LLC and Jaguar Health, Inc. for Series J to Series L Preferred Stock
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2025
Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (May 14, 2025)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2025
Waiver to Securities Purchase Agreement between Jaguar Health, Inc. and Buyers (May 2025)
Waiver Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Jaguar Health, Inc. Convertible Promissory Note Issued to Investor under Securities Purchase Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2025)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Placement Agent Common Stock Purchase Warrant between Jaguar Health, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Securities Purchase Agreement between Jaguar Health, Inc. and Buyers (March 26, 2025)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Registration Rights Agreement between Jaguar Health, Inc. and Buyers (March 26, 2025)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Jaguar Health, Inc. and Equiniti Trust Company, LLC Rights Agreement dated February 26, 2025
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (November 2024)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Amendment to At The Market Offering Agreement Among Jaguar Health, Inc., Ladenburg Thalmann & Co. Inc., and Lucid Capital Markets, LLC (July 17, 2024)
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Amendment to At The Market Offering Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co., Inc. (May 23, 2024)
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
First Amendment to Amended and Restated License Agreement between Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A.
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Exchange Agreement between Streeterville Capital, LLC and Jaguar Health, Inc. (March 1, 2024)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2024
Exchange Agreement between Jaguar Health, Inc. and Investor for Warrant-for-Share Exchange
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2024
First Amendment to Lease Agreement between M & E, LLC and Jaguar Health, Inc.
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Second Amendment to 200 Pine Street Office Lease between M & E, LLC and Jaguar Health, Inc.
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Uptown Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 1 to Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2023)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Exchange Agreement between Uptown Capital, LLC and Jaguar Health, Inc. for Series I Convertible Preferred Stock
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Memorandum of Understanding Modifying Warrant Allocation under Standstill Agreement among Jaguar Health, Napo Pharmaceuticals, Iliad Research, Uptown Capital, and Streeterville...
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
First Amendment to Manufacturing and Supply Agreement between Glenmark Life Sciences Limited and Napo Pharmaceuticals, Inc.
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Exchange Agreement between Jaguar Health, Inc. and Lender for Partitioned Royalty and Series H Convertible Preferred Stock
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
First Amendment to Standstill Agreement among Jaguar Health, Napo Pharmaceuticals, and Investors
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Second Amendment to Jaguar Health, Inc. 2020 New Employee Inducement Award Plan
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2023)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers (May 2023)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2023
Standstill Agreement among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Investors (Iliad, Uptown, Streeterville) dated May 8, 2023
Forbearance Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Mutual Termination of License Agreement between Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD, and Tao Wang
Termination Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2023
Jaguar Health, Inc. Stock Option Cancellation Agreement with Optionholder
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2022
Securities Purchase Agreement between Jaguar Health, Inc. and Purchaser (Series F Preferred Stock)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment to Secured Promissory Note and Note Purchase Agreement by and among Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC dated August 24, 2022
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC (August 24, 2022)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
Securities Purchase Agreement between Jaguar Health, Inc. and Purchaser (Series E Preferred Stock)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment to Royalty Interest Agreement between Streeterville Capital, LLC and Jaguar Health, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Amendment to At The Market Offering Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co., Inc. (February 2, 2022)
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
At the Market Offering Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc. dated December 10, 2021
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Office Sublease Agreement between Peacock Construction Inc. and Jaguar Health, Inc. dated August 31, 2020
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
Consent to Sublease Agreement among M&E, LLC, Peacock Construction, Inc., and Jaguar Health, Inc.
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2021
Placement Agency Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc. dated April 29, 2021
Agency Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Office Lease Agreement between M & E, LLC and Jaguar Health, Inc. for 200 Pine Street, San Francisco
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
First Amendment to Equity Purchase Agreement between Jaguar Health, Inc. and Oasis Capital, LLC
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC dated March 8, 2021
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Placement Agency Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc. dated January 13, 2021
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Office Sublease Agreement between Peacock Construction Inc. and Jaguar Health, Inc. dated August 31, 2020
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Consent to Sublease Agreement among M&E, LLC, Peacock Construction, Inc., and Jaguar Health, Inc.
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (October 2020)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Stock Plan Agreement for Payment of Contracted Research Fees between Jaguar Health, Inc. and PoC Capital, LLC
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
At the Market Offering Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc. dated October 5, 2020
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (September 1, 2020)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Stock Plan Agreement for Payment of Consulting Services between Jaguar Health, Inc. and Sagard Capital Partners
Consulting Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Jaguar Health, Inc. Severance and Change of Control Agreement with Executive
Severance Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Jaguar Health, Inc. New Employee Inducement Award Plan Stock Option Agreement
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Description of Jaguar Health, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Landlord Letter of Credit Agreement between Jaguar Health, Inc. and Charles Conte, M.D.
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
First Amendment to Exchange Agreement between Jaguar Health, Inc. and Oasis Capital, LLC
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Exchange Agreement between Jaguar Health, Inc. and Oasis Capital, LLC (December 23, 2019)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
China Life Science Advisory Agreement between Jaguar Health, Inc. and Angel Pond Capital LLC
Advisory Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
First Amendment to Landlord Letter of Credit & Warrant Issuance Agreement between Jaguar Health, Inc. and Pacific Capital Management, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Exchange Agreement between Chicago Venture Partners, L.P., Jaguar Health, Inc., and Napo Pharmaceuticals, Inc. (2019)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Jaguar Health, Inc. Underwriting Agreement with Ladenburg Thalmann & Co. Inc. for Public Offering of Securities
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Jaguar Health, Inc. Underwriting Agreement with Ladenburg Thalmann & Co. Inc. for Public Offering of Securities (July 2019)
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Exchange Agreement between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Chicago Venture Partners, L.P. (May 28, 2019)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Common Stock Purchase Agreement between Jaguar Health, Inc. and Oasis Capital, LLC dated April 1, 2019
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2019
Placement Agency Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc. dated March 24, 2019
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Common Stock Purchase Agreement between Jaguar Health, Inc. and Oasis Capital, LLC dated January 7, 2019
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2019
Standstill Agreement between Chicago Venture Partners, L.P. and Jaguar Health, Inc. dated October 1, 2018
Forbearance Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Underwriting Agreement for Public Offering of Common Stock and Warrants by Jaguar Health, Inc. and H.C. Wainwright & Co., LLC
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Jaguar Health, Inc. Convertible Promissory Note Issued to Charles Conte Dated September 11, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Securities Purchase Agreement between Jaguar Health, Inc. and Charles Conte dated September 11, 2018
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Office Lease Agreement between CA-Mission Street Limited Partnership and Jaguar Health, Inc. for Suite 2375 at 201 Mission Street, San Francisco
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Jaguar Health, Inc. Offer Letter to Robert Griffing for Chief Commercial Officer Position at Napo Pharmaceuticals
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
2018
Jaguar Health, Inc. Offer Letter to Robert Griffing for Chief Commercial Officer Position
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
2018
Management Services Agreement between Jaguar Health, Inc. and Sagard Capital Partners Management Corp. dated March 23, 2018
Management Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Consent and Payoff Agreement between Napo Pharmaceuticals, Inc. and Purchasers of Original Second Tranche Notes
Release Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Amendment and Consent to Underwriting Agreement between Jaguar Health, Inc. and Maxim Group LLC (October 25, 2017)
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Jaguar Health, Inc. Underwriting Agreement with Maxim Group LLC for Public Offering of Common Stock
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Amendment to Letter Agreement Regarding Registration Rights between Jaguar Health, Inc. and Kingdon Entities (August 31, 2017)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment to Debt and Warrant Settlement Agreement between Napo Pharmaceuticals, Inc. and Feinberg Parties (Dorsar Investment Company, Alco Investment Company, Two Daughters LLC)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Jaguar Animal Health, Inc. Warrant Repricing Letter Agreement with Holder (July 31, 2017)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Secured Convertible Promissory Note between Jaguar Animal Health, Inc. and Chicago Venture Partners, L.P. dated June 29, 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Subordination Agreement and Right to Purchase Debt among Chicago Venture Partners, L.P., Jaguar Animal Health, Inc., and Hercules Capital, Inc.
Subordination Agreement
Jaguar Health, Inc.
Pharmaceuticals
2017
Limited Subordination Agreement among Napo Pharmaceuticals, Kingdon Capital, Nantucket Investments, and Subordinated Lenders (2016)
Subordination Agreement
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Equity Commitment Letter between Invesco Asset Management Limited and Jaguar Animal Health, Inc. (February 21, 2017)
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Escrow Agreement among Jaguar Animal Health, Nantucket Investments Limited, and Citibank, N.A.
Escrow Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Separation and Release Agreement between John A. Kallassy and Jaguar Animal Health, Inc.
Separation Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
Underwriting Agreement between Jaguar Animal Health, Inc. and Aegis Capital Corp.
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2016
Formulation Development and GMP Manufacturing Agreement for Crofelemer Tablets between Patheon Pharmaceuticals Inc. and Jaguar Animal Health
Development Agreements
Jaguar Health, Inc.
Pharmaceuticals
OH
2016
Jaguar Animal Health, Inc. Executive Vice President of Finance Employment Offer Letter to Karen S. Wright
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Sublease Agreement between SeeChange Health Management LLC and Jaguar Animal Health, Inc. for 201 Mission Street, San Francisco
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
Consent to Sublease Agreement among CA-Mission Street Limited Partnership, SeeChange Health Management LLC, and Jaguar Animal Health, Inc.
Lease Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Underwriting Agreement between Jaguar Animal Health, Inc. and Aegis Capital Corp.
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Amended and Restated Standby Bridge Financing Agreement by and among GPB Life Science Holdings LLC, 31 Group LLC, and Jaguar Animal Health, Inc.
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Warrant Exercise Amendment between Jaguar Animal Health, Inc. and GPB Life Science Holdings LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Employment Agreement between Jaguar Animal Health, Inc. and Michael Hauser, D.V.M.
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
Jaguar Animal Health, Inc. Common Stock Underwriting Agreement with BMO Capital Markets Corp. and Guggenheim Securities, LLC (2014)
Underwriting Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2014
Jaguar Animal Health, Inc. Employment Agreement with John A. Kallassy (COO, CFO, and Treasurer)
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Separation and Release Agreement between Jaguar Animal Health, Inc. and Charlie (September 2014)
Separation Agreements
Jaguar Health, Inc.
Pharmaceuticals
2014
Jaguar Animal Health, Inc. Notice of Grant of Stock Option and Award Agreement under 2013 Equity Incentive Plan
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Restricted Stock Unit Grant Notice and Agreement under 2013 Equity Incentive Plan
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Restricted Stock Unit Grant Notice and Agreement under 2014 Stock Incentive Plan
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Chief Executive Officer Employment Agreement with Lisa A. Conte (March 1, 2014)
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Employment Offer Letter to Serge Martinod, D.V.M., Ph.D.
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Executive Employment Offer Letter to Steven R. King (2014)
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Executive Employment Agreement with Charles O. Thompson (CFO)
Employment Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Amended and Restated License and Services Agreement between Jaguar Health, Inc. and SynWorld Technologies Corporation
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Master Manufacturing Services Agreement between Patheon Pharmaceuticals Inc. and Napo Pharmaceuticals, Inc. (June 10, 2022)
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2022
First Amendment to License and Services Agreement between Jaguar Health, Inc. and SynWorld Technologies Corporation
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Amended and Restated License Agreement between Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A. (July 19, 2022)
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2022
License and Services Agreement between Jaguar Health, Inc. and SynWorld Technologies Corporation (June 28, 2022)
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment to Royalty Interest Agreement between Iliad Research and Trading, L.P. and Jaguar Health, Inc. (April 14, 2022)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Royalty Interest Agreement between Uptown Capital, LLC and Jaguar Health, Inc. (April 14, 2022)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
First Amendment to Jaguar Health, Inc. 2020 New Employee Inducement Award Plan
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers dated September 13, 2021
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
License Agreement between Napo Pharmaceuticals, Inc. and Napo EU S.p.A. dated August 18, 2021
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Investment and Subscription Agreement among DRAGON SPAC S.p.A., Napo Pharmaceuticals, Inc., and Joshua Mailman, dated June 1, 2021
Subscription Agreements
Jaguar Health, Inc.
Pharmaceuticals
2021
Manufacturing and Supply Agreement between Glenmark Life Sciences Limited and Napo Pharmaceuticals, Inc.
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2021
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers dated April 29, 2021
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Common Stock Purchase Warrant between Jaguar Health, Inc. and Oasis Capital, LLC dated April 7, 2021
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Registration Rights Agreement between Jaguar Health, Inc. and Oasis Capital, LLC dated April 7, 2021
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Master Services Agreement for Clinical Research Organization Services among Napo Pharmaceuticals, Integrium, and POC Capital (Effective June 24, 2019)
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2021
Master Services Agreement Between Napo Pharmaceuticals, Inc. and Integrium, LLC for Clinical Research Organization Services
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2021
Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC (March 8, 2021)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Secured Promissory Note between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Streeterville Capital, LLC dated January 19, 2021
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Note Purchase Agreement between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Streeterville Capital, LLC (January 19, 2021)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Security Agreement between Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC dated January 19, 2021
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers (January 13, 2021)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Royalty Interest Agreement between Jaguar Health, Inc. and Irving Park Capital, LLC (December 22, 2020)
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Irving Park Capital, LLC (December 22, 2020)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Manufacturing and Supply Agreement between Glenmark Life Sciences Limited and Napo Pharmaceuticals, Inc.
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Pre-Funded Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Fee Settlement Agreement between Jaguar Health, Inc. and Atlas Sciences, LLC (October 7, 2020)
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Jaguar Health, Inc. Royalty Interest Agreement with Iliad Research and Trading, L.P. (October 8, 2020)
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. dated October 8, 2020
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Global Amendment to Secured Promissory Note among Chicago Venture Partners, Napo Pharmaceuticals, and Jaguar Health
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
First Amendment to Accounts Receivable Purchase Agreement between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Oasis Capital, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Assignment Agreement to First Amendment of Accounts Receivable Purchase Agreement between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC
Assignment Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2020
First Amendment to Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Jaguar Health, Inc. New Employee Inducement Award Plan (Effective June 16, 2020)
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Jaguar Health, Inc. New Employee Inducement Grant Plan Restricted Stock Unit Agreement
Compensation Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Jaguar Health, Inc. Series 3 Common Stock Purchase Warrant Agreement
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Jaguar Health, Inc. Warrant Exercise Inducement Agreement with Holder – May 2020
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Jaguar Health, Inc. Inducement Offer to Exercise Common Stock Purchase Warrants Agreement (May 22, 2020)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Accounts Receivable Purchase Agreement between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Oasis Capital, LLC (May 12, 2020)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Assignment Agreement between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (May 12, 2020)
Assignment Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2020
Patent Purchase Agreement between Napo Pharmaceuticals, Inc. and Atlas Sciences, LLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
License Agreement Between Atlas Sciences, LLC and Jaguar Health, Inc. for Patent Rights (Excluding Greater China)
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Jaguar Health, Inc. 2014 Stock Incentive Plan (Amended and Restated Effective October 1, 2019)
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Jaguar Health, Inc. Securities Purchase Agreement with Purchasers Dated March 23, 2020
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Warrant Exercise and Preferred Stock Amendment Agreement between Jaguar Health, Inc. and Purchaser (March 24, 2020)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Leak-Out Agreement between Jaguar Health, Inc. and Ionic Ventures, LLC (March 24, 2020)
Jaguar Health, Inc.
Pharmaceuticals
2020
Equity Purchase Agreement between Jaguar Health, Inc. and Oasis Capital, LLC dated March 24, 2020
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Registration Rights Agreement between Jaguar Health, Inc. and Oasis Capital, LLC (March 24, 2020)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Royalty Interest Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. dated March 4, 2020
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. dated March 4, 2020
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Jaguar Health Warrant Repricing Letter Agreement with Holder (February 2020)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2020
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (December 2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers (December 20, 2019)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Lock-Up Agreement between Jaguar Health, Inc. and Restricted Holder (December 23, 2019)
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Pre-Funded Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (November 13, 2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers (November 13, 2019)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Unsecured Promissory Note between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Michael Tempesta dated October 1, 2019
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
License Termination and Settlement Agreement between Michael Tempesta and Jaguar Health, Inc. and Napo Pharmaceuticals, Inc.
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Jaguar Health, Inc. Warrant Exercise Agreement with Purchaser (October 2, 2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Amendment No. 1 to Registration Rights Agreement between Jaguar Health, Inc. and Sagard Capital Partners, L.P.
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Jaguar Health Promotion and Compensation Letter to Jonathan Wolin (September 2019)
Compensation Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Series 1 Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and CEDE & CO.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Series 2 Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and CEDE & CO.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Series 1 Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and CEDE & CO.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Series 2 Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and CEDE & CO.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Leak-Out Agreement between Jaguar Health, Inc. and Securities Holders (July 2019)
Waiver Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Series 1 Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and CEDE & CO.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Series 2 Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and CEDE & CO.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Warrant Agency Agreement between Jaguar Health, Inc. and American Stock Transfer & Trust Company, LLC (2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
First Amendment to Promissory Note between Jaguar Health, Inc. and Holder (2019)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Secured Promissory Note between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Chicago Venture Partners, L.P. dated July 31, 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Secured Promissory Note between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Chicago Venture Partners, L.P. dated July 31, 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Guaranty and Suretyship Agreement between Jaguar Health, Inc. and Chicago Venture Partners L.P.
Guaranty Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Security Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated May 28, 2019
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Security Agreement between Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P. dated May 28, 2019
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Jaguar Health, Inc. Common Stock Warrant Agreement with Jonathan Glaser (2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Letter of Credit Cancellation and Warrant Issuance Agreement between Jaguar Health, Inc. and LC Beneficiary (March 29, 2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Placement Agent Common Stock Purchase Warrant between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers (March 24, 2019)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Jaguar Health, Inc. Promissory Note Issued Pursuant to Securities Purchase Agreement (2019)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Jaguar Health, Inc. 12% Promissory Note Issued Pursuant to Securities Purchase Agreement (2019)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2019)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Securities Purchase Agreement between Jaguar Health, Inc. and Buyer (2019)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Registration Rights Agreement between Jaguar Health, Inc. and Buyer (2019)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Suspension, Settlement and Termination Agreement among Napo Pharmaceuticals, Jaguar Health, and SmartPharma
Termination Agreements
Jaguar Health, Inc.
Pharmaceuticals
NJ
2018
Pre-Funded Common Stock Purchase Warrant between Jaguar Health, Inc. and Holder (2018)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note between Jaguar Health, Inc. and L2 Capital, LLC dated September 11, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and L2 Capital, LLC (September 11, 2018)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Charles Conte dated September 11, 2018
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Securities Purchase Agreement between Jaguar Health, Inc. and L2 Capital, LLC dated September 11, 2018
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Registration Rights Agreement between Jaguar Health, Inc. and L2 Capital, LLC (September 11, 2018)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Registration Rights Agreement between Jaguar Health, Inc. and Charles Conte dated September 11, 2018
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Common Stock Warrant Agreement between Jaguar Health, Inc. and Pacific Capital Management, LLC (August 28, 2018)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Landlord Letter of Credit and Warrant Issuance Agreement between Jaguar Health, Inc. and LC Facilitator
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Amended and Restated Security Agreement among Napo Pharmaceuticals, Inc., Kingdon Capital Management, L.L.C., and Purchasers (July 31, 2017)
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Co-Promotion Agreement between Napo Pharmaceuticals, Inc. and RedHill Biopharma, Inc. dated June 28, 2018
Collaboration Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Collaboration and Revenue Sharing Agreement between Jaguar Health Inc. and SEED MENA Businessmen Services L.L.C.
Collaboration Agreements
Jaguar Health, Inc.
Pharmaceuticals
2018
Secured Promissory Note between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated March 21, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Series A Preferred Stock Purchase Agreement between Jaguar Health, Inc. and Sagard Capital Partners, L.P. (March 23, 2018)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Registration Rights Agreement between Jaguar Health, Inc. and Sagard Capital Partners, L.P. (March 23, 2018)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Jaguar Health, Inc. Share Purchase Agreement with Purchasers Dated March 23, 2018
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Securities Purchase Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated March 21, 2018
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Security Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated March 21, 2018
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Secured Promissory Note between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated February 26, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Securities Purchase Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated February 26, 2018
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Security Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated February 26, 2018
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Second Amended Original Issue Discount Exchangeable Promissory Note between Napo Pharmaceuticals, Inc. and Holder (Due May 1, 2018)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Second Amendment to Note Purchase Agreement and Notes and Payoff Agreement between Napo Pharmaceuticals, Inc. and Note Purchasers
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
First Amended Original Issue Discount Exchangeable Promissory Note between Napo Pharmaceuticals, Inc. and Holder (2017)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
First Amendment to Note Purchase Agreement and Notes by Napo Pharmaceuticals, Inc. and Purchasers
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Secured Promissory Note between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated December 8, 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Securities Purchase Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated December 8, 2017
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Jaguar Health, Inc. Security Agreement with Chicago Venture Partners, L.P. (December 8, 2017)
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Share Purchase Agreement between Jaguar Health, Inc. and L2 Capital, LLC dated November 24, 2017
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2017
Common Stock Purchase Agreement between Jaguar Health, Inc. and L2 Capital, LLC (November 24, 2017)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
KS
2017
Share Purchase Agreement between Jaguar Animal Health, Inc. and Invesco Asset Management Limited (July 31, 2017)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Termination, Asset Transfer and Transition Agreement between Napo Pharmaceuticals, Inc. and Glenmark Pharmaceuticals, Ltd. dated September 22, 2017
Termination Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Amendment to Note Purchase Agreement between Napo Pharmaceuticals, MEF I, LP, and Riverside Merchant Partners (September 1, 2017)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment to Debt Settlement Agreement between Napo Pharmaceuticals, Inc. and Boies Schiller Flexner LLP (September 1, 2017)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Amendment to Securities Purchase Agreement between Jaguar Health, Inc. and Chicago Venture Partners, L.P. (August 30, 2017)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Securities Purchase Agreement between Jaguar Animal Health, Inc. and Chicago Venture Partners, L.P. dated June 29, 2017
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Security Agreement between Jaguar Animal Health, Inc. and Chicago Venture Partners, L.P. dated June 29, 2017
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Employee Leasing and Overhead Allocation Agreement between Napo Pharmaceuticals, Inc. and Jaguar Animal Health, Inc. dated July 1, 2016
Services Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Amendment No. 1 to Employee Leasing and Overhead Allocation Agreement between Jaguar Animal Health, Inc. and Napo Pharma
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Equity Commitment Letter between Invesco Asset Management Limited and Jaguar Animal Health, Inc. (February 21, 2017)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
2017
Note Purchase Agreement between Napo Pharmaceuticals, Inc. and Purchasers (March 1, 2017)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Napo Pharmaceuticals, Inc. Exchangeable Promissory Note Due December 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Amended and Restated Note Purchase Agreement between Napo Pharmaceuticals, Inc. and Kingdon Entities (March 31, 2017)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Convertible Promissory Note between Napo Pharmaceuticals, Inc. and Holder under Amended and Restated Note Purchase Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Security Agreement among Napo Pharmaceuticals, Inc., Kingdon Capital Management, L.L.C., and Purchasers (December 30, 2016)
Security Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Settlement and Discounted Payoff Agreement among Napo Pharmaceuticals, Nantucket Investments, and Lenders
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Debt and Warrant Settlement Agreement between Napo Pharmaceuticals, Inc. and Feinberg Parties
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Debt Settlement Agreement between Boies Schiller Flexner LLP and Napo Pharmaceuticals, Inc.
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Debt Settlement Agreement between Napo Pharmaceuticals, Inc. and Dan Becka
Settlement Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Restricted Stock Unit Indemnification and Forfeiture Agreement among Jaguar Animal Health, Napo Pharmaceuticals, and RSU Holder
Indemnification Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Agreement and Plan of Merger among Jaguar Animal Health, Inc., Napo Acquisition Corporation, and Napo Pharmaceuticals, Inc.
Merger Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Investor Rights Agreement between Jaguar Animal Health, Inc. and Nantucket Investments Limited (March 31, 2017)
Investor Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Distribution Agreement between Jaguar Animal Health, Inc. and Butler Animal Health Supply, LLC d/b/a Henry Schein Animal Health
Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
OH
2017
License, Development, Co-Promotion and Commercialization Agreement between Jaguar Animal Health, Inc. and Elanco US Inc.
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2017
Jaguar Animal Health and Serious Change II LP Convertible Promissory Note and Warrant Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Binding Agreement of Terms for Jaguar Animal Health, Inc. Acquisition of Napo Pharmaceuticals, Inc. (February 8, 2017)
Merger Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Common Stock Purchase Warrant Agreement between Jaguar Animal Health, Inc. and Holder
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
Common Stock Purchase Warrant Agreement between Jaguar Animal Health, Inc. and Holder (2016)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
Common Stock Purchase Warrant Agreement between Jaguar Animal Health, Inc. and Holder
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
Common Stock Purchase Warrant Agreement between Jaguar Animal Health, Inc. and Holder
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
Securities Purchase Agreement between Jaguar Animal Health Inc. and Purchasers (November 22, 2016)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2016
Jaguar Animal Health, Inc. Registration Rights Agreement with Purchasers (November 22, 2016)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
2016
Supply and Distribution Agreement between Jaguar Animal Health, Inc. and Integrated Animal Nutrition and Health Inc.
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
Jaguar Animal Health and Serious Change II LP Convertible Note Repayment and Warrant Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
Letter of Intent for Proposed Merger Between Nairobi Pharmaceuticals Inc. and Johannesburg Animal Health Inc.
Merger Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2016
Jaguar Animal Health, Inc. 2014 Stock Incentive Plan (Amended and Restated Effective June 14, 2016)
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
Registration Rights Agreement between Jaguar Animal Health, Inc. and Aspire Capital Fund, LLC (June 8, 2016)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
IL
2016
Common Stock Purchase Agreement between Jaguar Animal Health, Inc. and Aspire Capital Fund, LLC dated June 8, 2016
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
IL
2016
First Amendment to Loan and Security Agreement and Waiver by Jaguar Animal Health, Inc. and Hercules Capital, Inc.
Loan Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
Manufacture and Supply Agreement between Glenmark Pharmaceuticals, Ltd. and Jaguar Animal Health Inc.
Supply Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Loan and Security Agreement among Jaguar Animal Health, Inc., Hercules Technology Growth Capital, Inc., and Lenders (August 18, 2015)
Loan Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Jaguar Animal Health, Inc. Exchange Warrant to Purchase Common Stock (December 3, 2014)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Representative's Warrant Agreement between Jaguar Animal Health, Inc. and Aegis Capital Corp.
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Jaguar Animal Health, Inc. Convertible Note Exercise Amendment (March 2015)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Jaguar Animal Health, Inc. Warrant and Note Exercise Amendment Agreement
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Jaguar Animal Health, Inc. Note Exercise Amendment and Conversion Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Convertible Note and Warrant Purchase Agreement between Jaguar Animal Health, Inc. and Dechra Pharmaceuticals PLC
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
Jaguar Animal Health, Inc. Convertible Promissory Note with Dechra Pharmaceuticals PLC (March 20, 2015)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Common Stock Warrant Agreement between Jaguar Animal Health, Inc. and Dechra Pharmaceuticals PLC (March 20, 2015)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Amended and Restated Exchange Warrant to Purchase Common Stock between Jaguar Animal Health, Inc. and Holder
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Jaguar Animal Health, Inc. Exchange Warrant to Purchase Common Stock (2014)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2015
Amendment No. 1 to Amended and Restated License Agreement between Napo Pharmaceuticals, Inc. and Jaguar Animal Health, Inc.
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Jaguar Animal Health, Inc. Convertible Note and Warrant Purchase Agreement with Investor (December 23, 2014)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2015
Jaguar Animal Health, Inc. Convertible Promissory Note Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Jaguar Animal Health, Inc. Common Stock Warrant Agreement
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Jaguar Animal Health, Inc. 2014 Stock Incentive Plan
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Warrant to Purchase Common Stock Agreement (October 30, 2014)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2014
Non-Disturbance of License Agreement among Napo Pharmaceuticals, Nantucket Investments, and Jaguar Animal Health
Jaguar Health, Inc.
Pharmaceuticals
NY
2014
Line of Credit Loan Agreement between Jaguar Animal Health, Inc. and Josh Mailman dated August 26, 2014
Loan Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Common Stock Warrant Agreement between Jaguar Animal Health, Inc. and Joshua Mailman (August 26, 2014)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2014
Investors' Rights Agreement between Jaguar Animal Health, Inc. and Investors (February 5, 2014)
Investor Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2014
Indemnification Agreement between Jaguar Animal Health, Inc. and Indemnitee
Indemnification Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2014
Jaguar Animal Health, Inc. 2013 Equity Incentive Plan
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
2014
Jaguar Animal Health, Inc. 2014 Stock Incentive Plan
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Stock Option Grant Notice and Agreement under 2014 Stock Incentive Plan
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014
Jaguar Animal Health, Inc. Notice of Grant of Restricted Stock and Restricted Stock Agreement
Bonus & Incentive Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2014